Research Article | | Peer-Reviewed

Health Disparities and Route of Repair of Fetal Myelomeningocele-Prenatal Versus Postnatal Repair

Received: 29 April 2024     Accepted: 31 May 2024     Published: 14 June 2024
Views:       Downloads:
Abstract

Background: Spina bifida (SB) is a relatively common birth defect with the highest prevalence among Hispanics. A randomized controlled trial (MOMS) demonstrated that prenatal repair yielded improved outcomes compared to postnatal repair. However, the social determinants of health can significantly impact the overall well-being of affected individuals or their eligibility for some of these evidenced-based interventions. Methods: We conducted a retrospective observational study to describe and compare the mean Child Opportunity Index (COIs) scores among patients treated at a free-standing children’s hospital who underwent either prenatal or postnatal repair of SB from January 1st, 2012, to December 31st, 2021. We excluded patients with identifiable maternal and fetal contraindications to prenatal repair, as per the MOMS trial eligibility, apart from those pertaining to socio-economic status. RESULTS: Among a total cohort of 51 fetuses, 86% (n = 44) underwent postnatal repair for SB, while 14% (n = 7) received prenatal repair. Patients who underwent prenatal repair exhibited lower COI scores across all domains (education, health, and environment, social and economic) on national, state, and metro levels compared to the postnatal group. Our cohort showed a higher percentage of primary commercial insurance in the prenatal (fetal) surgery group (57.14%) versus the postnatal surgery group (47.73%), without attaining statistical significance (p=0.25). Conclusion: While COI scores across all domains were lower in the prenatal cohort, our data does not suggest a statistically significant difference between prenatal and postnatal surgery groups. This highlights the need for future studies with larger sample sizes to further explore and define this relationship.

Published in Advances in Surgical Sciences (Volume 12, Issue 1)
DOI 10.11648/j.ass.20241201.15
Page(s) 27-35
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Spina Bifida, Fetal Surgery, COI, Health Disparities, MMC, Myelomeningocele

References
[1] Kancherla V, Wagh K, Johnson Q, Oakley GP, Jr. A 2017 global update on folic acid-preventable spina bifida and anencephaly. Birth Defects Res. 2018; 110: 1139-1147.
[2] Mai CT, Isenburg JL, Canfield MA, et al. National population-based estimates for major birth defects, 2010-2014. Birth Defects Res. 2019; 111: 1420-1435.
[3] Grosse SD, Berry RJ, Mick Tilford J, Kucik JE, Waitzman NJ. Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S. Am J Prev Med. 2016; 50: S74-S80.
[4] Sacco A, Simpson L, Deprest J, David AL. A study to assess global availability of fetal surgery for myelomeningocele. Prenat Diagn. 2018; 38: 1020-1027.
[5] Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011; 364: 993-1004.
[6] Wallace ME, Mendola P, Kim SS, et al. Racial/ethnic differences in preterm perinatal outcomes. Am J Obstet Gynecol. 2017; 216: 306 e301-306 e312.
[7] Wang C, Guttmann A, To T, Dick PT. Neighborhood income and health outcomes in infants: how do those with complex chronic conditions fare? Arch Pediatr Adolesc Med. 2009; 163: 608-615.
[8] Schechter MS, Liu T, Soe M, Swanson M, Ward E, Thibadeau J. Sociodemographic attributes and spina bifida outcomes. Pediatrics. 2015; 135: e957-964.
[9] Smith KA, Liu T, Freeman KA, et al. Differences in continence rates in individuals with spina bifida based on ethnicity. J Pediatr Rehabil Med. 2019; 12: 361-368.
[10] Acevedo-Garcia D, McArdle N, Hardy EF, et al. The child opportunity index: improving collaboration between community development and public health. Health Aff (Millwood). 2014; 33: 1948-1957.
[11] Foy AB, Sawin KJ, Derflinger T, et al. Sociodemographic disparities in fetal surgery for myelomeningocele: a single-center retrospective review. J Neurosurg Pediatr. 2021: 1-5.
[12] Fabelo C, He H, Lim FY, Atzinger C, Wong B. Factors impacting surgical decision making between prenatal and postnatal repair for myelomeningocele. Prenat Diagn. 2022; 42: 27-36.
[13] Wilpers A, Lynn AY, Eichhorn B, et al. Understanding Sociodemographic Disparities in Maternal-Fetal Surgery Study Participation. Fetal Diagn Ther. 2022; 49: 125-137.
[14] Harbert AL, Barnett RR, Abumoussa AL, Goodnight WH, Tolleson-Rinehart S, Quinsey CS. Sociodemographic disparities as a determinant of fetal versus postnatal surgical myelomeningocele repair. J Neurosurg Pediatr. 2022: 1-7.
[15] Julie S Moldenhauer, N Scott Adzick. Fetal surgery for myelomeningocele: After the Management of Myelomeningocele Study (MOMS). Semin Fetal Neonatal Med. 2017 Dec; 22(6): 360-366.
[16] Child Opportunity Index Methodology and Application - CHA Webinar - Dec 2021.pdf.
Cite This Article
  • APA Style

    Ogunleye, O., Xia, J., Cruz, S., Saulsbery, A., Nicoll, R., et al. (2024). Health Disparities and Route of Repair of Fetal Myelomeningocele-Prenatal Versus Postnatal Repair. Advances in Surgical Sciences, 12(1), 27-35. https://doi.org/10.11648/j.ass.20241201.15

    Copy | Download

    ACS Style

    Ogunleye, O.; Xia, J.; Cruz, S.; Saulsbery, A.; Nicoll, R., et al. Health Disparities and Route of Repair of Fetal Myelomeningocele-Prenatal Versus Postnatal Repair. Adv. Surg. Sci. 2024, 12(1), 27-35. doi: 10.11648/j.ass.20241201.15

    Copy | Download

    AMA Style

    Ogunleye O, Xia J, Cruz S, Saulsbery A, Nicoll R, et al. Health Disparities and Route of Repair of Fetal Myelomeningocele-Prenatal Versus Postnatal Repair. Adv Surg Sci. 2024;12(1):27-35. doi: 10.11648/j.ass.20241201.15

    Copy | Download

  • @article{10.11648/j.ass.20241201.15,
      author = {Oluseyi Ogunleye and Jason Xia and Stephanie Cruz and Angela Saulsbery and Ryan Nicoll and Amy Schlegel and Adolfo Etchegaray and Eric Sribnick and Oluyinka Olutoye},
      title = {Health Disparities and Route of Repair of Fetal Myelomeningocele-Prenatal Versus Postnatal Repair
    },
      journal = {Advances in Surgical Sciences},
      volume = {12},
      number = {1},
      pages = {27-35},
      doi = {10.11648/j.ass.20241201.15},
      url = {https://doi.org/10.11648/j.ass.20241201.15},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ass.20241201.15},
      abstract = {Background: Spina bifida (SB) is a relatively common birth defect with the highest prevalence among Hispanics. A randomized controlled trial (MOMS) demonstrated that prenatal repair yielded improved outcomes compared to postnatal repair. However, the social determinants of health can significantly impact the overall well-being of affected individuals or their eligibility for some of these evidenced-based interventions. Methods: We conducted a retrospective observational study to describe and compare the mean Child Opportunity Index (COIs) scores among patients treated at a free-standing children’s hospital who underwent either prenatal or postnatal repair of SB from January 1st, 2012, to December 31st, 2021. We excluded patients with identifiable maternal and fetal contraindications to prenatal repair, as per the MOMS trial eligibility, apart from those pertaining to socio-economic status. RESULTS: Among a total cohort of 51 fetuses, 86% (n = 44) underwent postnatal repair for SB, while 14% (n = 7) received prenatal repair. Patients who underwent prenatal repair exhibited lower COI scores across all domains (education, health, and environment, social and economic) on national, state, and metro levels compared to the postnatal group. Our cohort showed a higher percentage of primary commercial insurance in the prenatal (fetal) surgery group (57.14%) versus the postnatal surgery group (47.73%), without attaining statistical significance (p=0.25). Conclusion: While COI scores across all domains were lower in the prenatal cohort, our data does not suggest a statistically significant difference between prenatal and postnatal surgery groups. This highlights the need for future studies with larger sample sizes to further explore and define this relationship. 
    },
     year = {2024}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Health Disparities and Route of Repair of Fetal Myelomeningocele-Prenatal Versus Postnatal Repair
    
    AU  - Oluseyi Ogunleye
    AU  - Jason Xia
    AU  - Stephanie Cruz
    AU  - Angela Saulsbery
    AU  - Ryan Nicoll
    AU  - Amy Schlegel
    AU  - Adolfo Etchegaray
    AU  - Eric Sribnick
    AU  - Oluyinka Olutoye
    Y1  - 2024/06/14
    PY  - 2024
    N1  - https://doi.org/10.11648/j.ass.20241201.15
    DO  - 10.11648/j.ass.20241201.15
    T2  - Advances in Surgical Sciences
    JF  - Advances in Surgical Sciences
    JO  - Advances in Surgical Sciences
    SP  - 27
    EP  - 35
    PB  - Science Publishing Group
    SN  - 2376-6182
    UR  - https://doi.org/10.11648/j.ass.20241201.15
    AB  - Background: Spina bifida (SB) is a relatively common birth defect with the highest prevalence among Hispanics. A randomized controlled trial (MOMS) demonstrated that prenatal repair yielded improved outcomes compared to postnatal repair. However, the social determinants of health can significantly impact the overall well-being of affected individuals or their eligibility for some of these evidenced-based interventions. Methods: We conducted a retrospective observational study to describe and compare the mean Child Opportunity Index (COIs) scores among patients treated at a free-standing children’s hospital who underwent either prenatal or postnatal repair of SB from January 1st, 2012, to December 31st, 2021. We excluded patients with identifiable maternal and fetal contraindications to prenatal repair, as per the MOMS trial eligibility, apart from those pertaining to socio-economic status. RESULTS: Among a total cohort of 51 fetuses, 86% (n = 44) underwent postnatal repair for SB, while 14% (n = 7) received prenatal repair. Patients who underwent prenatal repair exhibited lower COI scores across all domains (education, health, and environment, social and economic) on national, state, and metro levels compared to the postnatal group. Our cohort showed a higher percentage of primary commercial insurance in the prenatal (fetal) surgery group (57.14%) versus the postnatal surgery group (47.73%), without attaining statistical significance (p=0.25). Conclusion: While COI scores across all domains were lower in the prenatal cohort, our data does not suggest a statistically significant difference between prenatal and postnatal surgery groups. This highlights the need for future studies with larger sample sizes to further explore and define this relationship. 
    
    VL  - 12
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • The Fetal Center, Nationwide Children’s Hospital, Columbus, The United States; Department of Maternal Fetal Medicine, Nationwide Children’s Hospital, Columbus, The United States

  • Department of Surgery, Nationwide Children’s Hospital, Columbus, The United States; Department of Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, The United States

  • The Fetal Center, Nationwide Children’s Hospital, Columbus, The United States; Department of Surgery, Nationwide Children’s Hospital, Columbus, The United States

  • Department of Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, The United States

  • The Fetal Center, Nationwide Children’s Hospital, Columbus, The United States

  • Department of Pediatrics, The Ohio State University School of Medicine, Columbus, The United States; Division of Neonatology, Nationwide Children’s Hospital, Columbus, The United States

  • Department of Maternal Fetal Medicine, Nationwide Children’s Hospital, Columbus, The United States

  • Department of Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, The United States; Department of Neurosurgery, Nationwide Children’s Hospital, Columbus, The United States; Department of Neurosurgery, The Ohio State University College of Medicine, Columbus, The United States

  • The Fetal Center, Nationwide Children’s Hospital, Columbus, The United States; Department of Surgery, Nationwide Children’s Hospital, Columbus, The United States; Department of Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, The United States; Department of Surgery, The Ohio State University College of Medicine, Columbus, The United States

  • Sections